• 1. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 2. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 3. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 4. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 5. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Prenol lipids Terpene glycosides
• Natural Products and Extracts Plant Extracts Plant based Ducrosia anethifolia

8-Debenzoylpaeoniflorin (CAS No. 23532-11-8): A Comprehensive Overview of Its Properties and Applications

8-Debenzoylpaeoniflorin (CAS No. 23532-11-8) is a naturally occurring monoterpene glycoside derived from the roots of Paeonia lactiflora, commonly known as the Chinese peony. This compound has garnered significant attention in recent years due to its potential therapeutic properties and applications in traditional and modern medicine. With the growing interest in natural products and plant-derived bioactive compounds, 8-Debenzoylpaeoniflorin has become a subject of extensive research, particularly in the fields of pharmacology and nutraceuticals.

The chemical structure of 8-Debenzoylpaeoniflorin features a glucose moiety attached to a monoterpene skeleton, which is responsible for its unique biological activities. Unlike its parent compound, paeoniflorin, 8-Debenzoylpaeoniflorin lacks the benzoyl group, making it less lipophilic and potentially more water-soluble. This structural modification may influence its pharmacokinetic properties, such as absorption and distribution in the body, which is a key consideration for researchers exploring its therapeutic potential.

One of the most frequently searched topics related to 8-Debenzoylpaeoniflorin is its role in anti-inflammatory and neuroprotective effects. Recent studies suggest that this compound may modulate inflammatory pathways by inhibiting the production of pro-inflammatory cytokines, such as TNF-α and IL-6. These properties make it a promising candidate for managing chronic inflammatory conditions, which are a major focus in today's healthcare landscape. Additionally, its potential to cross the blood-brain barrier has sparked interest in its application for neurodegenerative diseases like Alzheimer's and Parkinson's.

Another area of growing interest is the antioxidant capacity of 8-Debenzoylpaeoniflorin. Oxidative stress is a common denominator in many chronic diseases, and natural antioxidants are increasingly sought after as safer alternatives to synthetic compounds. Research indicates that 8-Debenzoylpaeoniflorin can scavenge free radicals and enhance the activity of endogenous antioxidant enzymes, such as superoxide dismutase (SOD) and glutathione peroxidase (GPx). This has led to its exploration in skincare formulations, where oxidative damage is a primary concern.

The pharmacokinetics and metabolism of 8-Debenzoylpaeoniflorin are also hot topics among researchers. Understanding how the compound is absorbed, distributed, metabolized, and excreted is crucial for its development as a therapeutic agent. Preliminary studies suggest that it undergoes hydrolysis in the gastrointestinal tract, releasing its aglycone form, which may be responsible for its bioactive effects. This insight is valuable for formulating delivery systems that enhance its bioavailability.

In the realm of traditional Chinese medicine (TCM), 8-Debenzoylpaeoniflorin is often associated with the therapeutic effects of Paeonia lactiflora extracts. TCM practitioners have long used peony root to treat conditions like pain, inflammation, and menstrual disorders. Modern scientific investigations are now validating these traditional uses, with 8-Debenzoylpaeoniflorin identified as one of the key active constituents. This bridge between ancient wisdom and contemporary science is a compelling narrative for consumers and researchers alike.

The market for 8-Debenzoylpaeoniflorin is expanding, driven by the rising demand for natural and plant-based therapeutics. With increasing consumer awareness about the side effects of synthetic drugs, there is a shift toward safer, natural alternatives. This trend is reflected in the growing number of dietary supplements and functional foods incorporating Paeonia lactiflora extracts. Companies are also exploring its use in cosmeceuticals, leveraging its anti-aging and skin-soothing properties.

Quality control and standardization of 8-Debenzoylpaeoniflorin are critical for its commercial success. Analytical techniques like HPLC and LC-MS are commonly employed to quantify the compound in plant extracts and finished products. Ensuring consistent potency and purity is essential for meeting regulatory requirements and consumer expectations. This aspect is particularly relevant for manufacturers looking to capitalize on the compound's therapeutic potential.

Future research on 8-Debenzoylpaeoniflorin is likely to focus on its molecular mechanisms and clinical applications. While preclinical studies have shown promising results, well-designed clinical trials are needed to establish its efficacy and safety in humans. Collaborative efforts between academia and industry will be key to unlocking its full potential. As the scientific community continues to explore this fascinating compound, 8-Debenzoylpaeoniflorin is poised to become a cornerstone in the development of next-generation natural therapeutics.

In summary, 8-Debenzoylpaeoniflorin (CAS No. 23532-11-8) is a bioactive compound with diverse applications in medicine, skincare, and nutraceuticals. Its anti-inflammatory, neuroprotective, and antioxidant properties make it a valuable subject of research, aligning with current trends in health and wellness. As interest in plant-derived compounds grows, 8-Debenzoylpaeoniflorin stands out as a promising candidate for addressing some of today's most pressing health challenges.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)